Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Senju's new aldose reductase inhibitors have potential for diabetic complications

June 23, 2000

New compounds synthesized at Teijin favorably affect lipid profiles

June 23, 2000

Thrombopoietin preparation shows no clinical benefit in myeloid leukemia

June 23, 2000

Extensive pharmacological characterization of NN-2211 reported at recent diabetes meeting

June 22, 2000

Potent inhibition of bone resorption demonstrated for the NO-NSAID HCT-1026

June 22, 2000

FDA grants approval to Novo Nordisk's liquid Norditropin

June 22, 2000

First drug to reverse effects of Fabry's disease developed at U. of Michigan

June 22, 2000

GH secretagogues and their use described by Pfizer

June 22, 2000

ImClone Systems and Princeton launch genomics program

June 22, 2000

Major European launch for Actonel

June 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...